MR 1883, a novel cardioselective inhibitor of the atp-sensitive potassium channel. Part II: Effects on susceptibility to ventricular fibrillation induced by myocardial ischemia in conscious dogs

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 3, 1998, Pages 1465-1473

  Billman, George E ^a,b   Englert, Heinrich C ^a,b   Schölkens, Bernward A ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CLAMIKALANT; GLIBENCLAMIDE; GLUCOSE; INSULIN; POTASSIUM; POTASSIUM CHANNEL; SULFONYLUREA DERIVATIVE; THIOUREA DERIVATIVE; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATE; DRUG DERIVATIVE; POTASSIUM CHANNEL BLOCKING AGENT; SULFONAMIDE; THIOUREA;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY HEMODYNAMICS; DOG; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG STRUCTURE; GLUCOSE BLOOD LEVEL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART MUSCLE POTENTIAL; HEART MUSCLE REFRACTORY PERIOD; HEART VENTRICLE CONTRACTILITY; HEART VENTRICLE FIBRILLATION; INSULIN BLOOD LEVEL; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; ANIMAL; HEART; HEMODYNAMICS; NERVE CONDUCTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; DOGS; GLYBURIDE; HEART; HEMODYNAMIC PROCESSES; MYOCARDIAL ISCHEMIA; POTASSIUM CHANNEL BLOCKERS; REFRACTORY PERIOD, ELECTROPHYSIOLOGICAL; SULFONAMIDES; THIOUREA; VENTRICULAR FIBRILLATION;

EID: 0032160464     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Aversano T, Ouryang P and Silverman H (1991) Blockade of the ATP-sensitive potassium channel modulates reactive hyperemia in the canine coronary circulation. Circ Res 69:618-622.
2. Bekheit S, Restivo M, Boutjder M, Henkin R, Gooyandeh K, Assadi M, Khatib S, Gough WB and El-sherif N (1990) Effects of glyburide on ischemia-induced changes in extracellular potassium accumulation and local myocardial activation: A potential new approach to management of ischemia-induced ventricular arrhythmias. Am Heart. J 119:1025-1033.
3. Bellemin-Baurreau J, Poizot A, Hicks PE, Rochette L and Armstrong JM (1994) Effects of ATP-dependent K+ channel modulators on ischemia-reperfusion rabbit isolated heart model with programmed electrical stimulation. Ear J Pharmacnl 256:115-124.
4. Belloni FI and Hintze TH (1991) Glibenclamide attenuates adenosine-induced bradycardia and vasodilation. Am J Physiol 261:H720-H727.
5. Billman GE (1987) Effects of aminophylline on behaviorally induced coronary blood flow increases. Am J Physiol 253 (Heart Circ. Physiol. 22):H548-H555.
6. Billman GE ( 1994) The role of the ATP-sensitive K+ channel in K+ accumulation and cardiac arrhythmias during myocardial ischemia. Cardiovasc Res 28:762-769.
7. Billman GE and Hamlin RL (1996) The effects of mibefradil, a novel calcium channel antagonist on ventricular arrhythmias induced by ischemia and programmed electrical stimulation. J Pharmacol Exp Thcr 277:1517-1526.
8. Billman GE, Avendano CE, Halliwill JR and Burroughs JM (1993) The effect of the ATP-dependent potassium channel antagonist glyburide on coronary blood flow and susceptibility to ventricular fibrillation in unanesthetized dogs. J Cardiovasc Pharmacol 21:197-204.
9. Billman GE, Castillo LC, Hensley J, Hohl CM and Altschuld RA ( 1997) fe-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to β%-adrenergic stimulation in animals susceptible to sudden death. Circulation 96:1914-1922.
10. Cacciapuoti F, Spiezia R, Bianchi M, Lama D. D'Avino M and Varricchio M (1991) Effectiveness of glibenclamide on myocardial ischémie ventricular arrhythmias in non-insulin dependent diabetes mellitus. Am J Cardiol 67:843-847.
11. Cavero I, Mondot S and Mestre M (1989) Vasorelaxant effects of cromakalim in ratî are modulated by glibenclamide-sensitive potassium channels. J Pharmacol Exp Ther 248:1261-1268.
12. Chi L, Black SC, Kuo PI, Fagbemi SO and Lucchesi BR (1993) Actions of pinacidil at a reduced potassium concentration: A direct cardiac action possibly involving the ATP-dependent potassium channel. J Cardiovasc Pharmacol 21:179-190.
13. Chi L, Uprichard ACG and Lucchesi BR (1990) Profibrillatory actions of pinacidil in a conscious canine model of sudden coronary death. J Cardiovasc Pharmaco.' 15:452-464.
14. Cole WC, McPherson CD and Sontag D (1991) ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage. Circ Res 69:571-581.
15. Coronel R (1994) Heterogeneity in extracellular potassium concentration during early myocardial ischaemia and reperfusion: Implications for arrhythmogenesis Cardiovasc Res 28:770-777.
16. Coronel R, Piolet JWT, Wilms-Schopman FJG, Schaapherder AFM, Johnson TA, Gettes LS and Janse MJ (1988) Distribution of extracellular potassium and its relation to electrophysiologic changes in the isolated porcine heart. Circulation 71:1125-1138.
17. Daut J, Maier-Rudolph W, von Beckenrath N, Mehrke G, Günther K and GodelMeinen I (1990) Hypoxie dilation of coronary arteries is mediated by ATP-sensitive potassium channels. Science 247:1341-1344.
18. Davis TME, Parson RW, Broadhurst R, Hobbs M and Jamrozik K (1996) Arrhythmias and mortality after myocardial infarction in diabetic patients: relationship to diabetes treatment. Diabetologia 39:A51.
19. Di Diego JM and Antzelevitch C (1993) Pinacidil-induced electrical heterogeneity and extrasystolic activity in canine ventricular tissue: Does activation of ATPregulated potassium current promote phase 2 reentry? Circulation 88:1177-1189.
20. Garlid KD, Paucek P, Yarov-Yarovoy V, Murray HN, Darbenzio RB, D'Alonzo AJ, Lodge NJ, Smith MA and Grover GJ ( 1997) Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive Kchannels: Possible mechanism of cardioprotection. Cire Res 81:1072-1082.
21. Gillum R (1989) Sudden coronary death in the United States 1980-1985. Circulation 79:756-765.
22. Gögelein H, Härtung J, Englert HC and Schölkens BA (1998) HMR 1883, a novel cardioselective inhibitor of the ATP-sensitive potassium channel. Part I: Effects on cardiomyocytes, coronary flow and pancreatic (3-cells. J Pharmacol Exp Ther 286:1453-1464.
23. Grover GJ, D'Alonzo AJ, Hess T, Sleph PG and Darbenzio RB (1995) Gyburiderevisible Cardioprotective effect of BMS-180448 is independent of action potential shortening. Cardiouasc Res 30:731-738.
24. Gwilt M, Henderson CG, Orme J and Rourke JD ( 1992) Effect of drugs on ventricular fibrillation and ischaemic K+ loss in a model of ischaemia in perfused guinea pig hearts in vitro. Eur J Pharmacol 220:231-236.
25. Harris AS ( 1966) Potassium and experimental coronary occlusion. Am Heart J 71:797-802.
26. Hearse DJ (1995) Activation of the ATP-sensitive potassium channels: A novel pharmacological approach to myocardial protection? Cardiovasc Res 30:1-17.
27. Hicks MN and Cobbe SM (1991) Effect of glibenclamide on extracellular potassium accumulation and the electrophysiological changes during myocardial ischaemia in the arterially perfused interventricular septum of rabbit. Cardiouasc Res 25: 407-413.
28. Inagaki N, Gonoi T, Clement JP IV, Wang C-Z, Aguilar-Bryan L, Bryan J and Seino S ( 1996) A family of sulfonylurea receptors determines the pharmacological properties of ATP-sensitive K+ channels. Neuron 16:1011-1017.
29. Isomoto S, Kondo C, Yamada M, Matsumoto S, Higashiguchi O, Horio Y, Matsuzawa Y and Kurachi Y (1996) A novel sulfonylurea receptor forms with BIR (Kir6.2) a smooth muscle type ATP-sensitive 1C channel. J Bial Chem 40:24321-24324.
30. Janse MJ and Wit AS (1989) Electrophysiological mechanisms of ventricular arrhythmias resulting from myocardial ischemia and infarction. Physiol Rev 69: 1049-1169.
31. Kantor PF, Coetzee WA, Carmeliet EE, Dennis SC and Opie LH (1990) Reduction of ischémie K+ loss and arrhythmias in rat hearts: Effect of glibenclamide, a sulfonylurea. Circ Res 66:478-485.
32. Kleber AG (1984) Extracellular potassium accumulation in acute myocardial ischemia. J Mol Cell Cardiol 16:389-394.
33. Krause E, Englert HC and Gögelein H (1995) Adensosine triphosphate-dependent K currents activated by metabolic inhibition in rat ventricular myocytes differ from those elicted by channel opener rilmakalim. Pflugers Arch 429:625-635.
34. Kubota I, Yamaki M, Shibata T, Ikeno E, Hosoya Y and Tomoike H (1993) Role of ATP-sensitive K+ channel on ECG ST segment elevation during a bout of myocardial ischemia: A study on epicardial mapping in dogs. Circulation 88:18451851.
35. Li G-R and Ferrier GR (1991) Effects of lidocaine on reperfusion arrhythmias and electrophysiological properties in an isolated ventricular muscle model of ischemia and reperfusion. J Pharmacol Exp Ther 257:997-1004.
36. Lomuscio A and Florentin! C (1996) Influence of oral antidiabetic treatment on electrocardiac alterations induced by myocardial ischemia. Diabetes Res Clin Pract 31:S21-S26.
37. Lomuscio A, Vergani D, Marano L, Castagnone M and Florentin! C (1994) Effects of glibenclamide on ventricular fibrillation in non-insulin-dependent diabetes with acute myocardial infarction. Coron Artery Dis 5:767-771.
38. + blockers on the action potential shortening in hypoxic and ischaemic myocardium. Br J Pharmacol 103:1019-1026.
39. Nichols CG, Ripoll C and Lederer WJ (1991) ATP-sensitive potassium channel modulation of guinea pig ventricular action potential and contraction. Circ Res 68:280-287.
40. Noma A (1983) ATP-regulated K+ channel in cardiac muscle. Nature 305:147-149.
41. Opie LH, Nathan D and Lubbe WF (1979) Biochemical aspects of arrhythmogenesis. Am J Cardiol 43:131-148.
42. Ruiz-Petrich E, Leblanc N, de Lorenzi F, Allard Y and Schanne OF (1992) Effects of K+ channel blockers on action potential of hypoxic rabbit myocardium. Br J Pharmacol 106:924-930.
43. Saito D, Steinhart CR, Nixon DG and Olsson RA (1981) Intracoronary adenosine deaminase reduces canine myocardial reactive hyperemia. Circ Res 49:1262-1267.
44. Schwartz PJ, Billman GE and Stone HL (1984) Autonomie mechanisms in ventricular fibrillation due to acute myocardial ischemia during exercise in dogs with healed myocardial infarction: An experimental model for sudden cardiac death. Circulation 69:790-800.
45. Sturgess NC, Ashford MLJ, Cook DL and Hales CN (1985) The sulphonylurea receptor may be an ATP-sensitive potassium channel. Lancet 2:474-475.
46. Takizawa T, Kara Y, Saito T, Masuda Y and Nakaya H (1996) aradrenoceptor stimulation partially inhibits ATP-sensitive Kcurrent in guinea pig ventricular cells: Attenuation of the action potential shortening induced by hypoxia and K+ channel openers. J Cardiovasc Pharmacol 28:799-808.
47. Tosaki A and Hellegouarch A (1994) Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates ischemia/ reperfusion-induced injury: Heart function studies in nonfibrillating isolated hearts. J Am Coll Cardiol 23:487-496.
48. Tweedie D, Henderson C and Kane K (1993) Glibenclamide but not class III drugsprevents ischaemic shortening of refractory period in guinea-pig hearts. Eur J Pharmacol 240:251-258.
49. Vanhell B and de Hemptinne A (1992) Influence of KATP channel on modulation on net potassium efflux from ischaemic mammalian cardiac tissue. Cardiovasc Res 26:1030-1039.
50. Venkatesh N, Lamp ST and Weiss JN (1991) Sulfonylurea, ATP-sensitive K+ channels, and cellular K1 loss during hypoxia, ischemia and metabolic inhibition in mammalian ventricle. Circ Res 69:623-647.
51. Venkatesh N, Stuart JS, Lamp ST, Alexander LD and Weiss JN (1992) Activation of ATP-sensitive K+ channels by cromakalim: Effects on cellular K+ loss and cardiac function in ischémie and reperfused mammalian ventricle. Circ Res 71:1324-1333.
52. Wilde AAM, Escande D, Schumacher CA, Thüringer D, Mestre M, Foilet JWT and Janse MJ (1990) Potassium accumulation in globally ischémie mammalian heart: A role for the ATP-sensitive potassium channel. Circ Res 67:835-843.
53. Wolleben CD, Sanguinette MC and Siegl PK (1989) Influence of ATP-sensitive potassium channel modulators on ischemia-induced fibrillation in isolated rat hearts. J Mol Cell Cardiol 21:783-788.